I’m contacting you with a quick update that CDRD and the MS Society of Canada have issued a global call for research projects focused on the discovery and development of treatments for progressive Multiple Sclerosis (MS).
This is the third call in our ongoing partnership with the MS Society which is aimed at accelerating preclinical development of novel therapies for MS. To achieve this goal, the organizations are seeking pre-proposals from investigators who are working on research projects aimed at developing new disease-modifying therapies for progressive MS. Such therapies may include novel approaches to promote remyelination, repair existing damage and/or protecting neurons to positively impact the progressive forms of the disease.
Feel free to contact me at your convenience with any questions or comments.
Nicolette Honson Ph.D.
Scientist, Project Search and Evaluation
CDRD - The Centre for Drug Research and Development
2405 Wesbrook Mall, Fourth Floor | Vancouver, BC V6T 1Z3 | Main: (604) 827-1147